Bicycle Therapeutics appoints Alethia Young as its new CFO

Bicycle Therapeutics (BCYC) announced the appointment of Alethia Young as its new CFO, effective July 17. Young joins Bicycle from Graphite Bio, where she served as CFO, and previously served as senior biotech analyst and head of research at Cantor Fitzgerald. In addition, Bicycle announced the promotion of Travis Thompson, senior VP, finance, to senior VP, chief accounting officer. Thompson will work alongside Young, overseeing the company’s financial and accounting operations.